Cox Christopher Nixon
Insider CIK 2008212 · ANRO Director · NMAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMAX Newsmax Inc. | A Award deriv | 2026-05-20 | 2026-05-21 | 23,940 | — | $0 | 23,940 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 7,189 | $11.82 | $85.0K | 7,189 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2025-05-13 | 2025-05-15 | 15,287 | — | $0 | 15,287 | SEC↗ |
| NMAX Newsmax Inc. | A Award deriv | 2025-03-28 | 2025-04-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 25,236 | $3.17 | $80.0K | 25,236 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-07 | 1,250,000 | — | $0 | 0 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-07 | 281,917 | — | $0 | 0 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion | 2024-02-06 | 2024-02-07 | 588,898 | — | $0 | 588,898 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion | 2024-02-06 | 2024-02-07 | 126,755 | — | $0 | 715,653 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 4,623 | $11.88 | $54.9K | 4,623 | SEC↗ |